Pfizer Limited

Company Profile

Pfizer Limited had its IPO on under the ticker symbol PFIZER.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Pfizer Limited has a staff strength of 1,702 employees.

Stock update

Shares of Pfizer Limited opened at ₹3848.55 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹3810 - ₹3889.8, and closed at ₹3837.5.

This is a -0.24% slip from the previous day's closing price.

A total volume of 3,909 shares were traded at the close of the day’s session.

In the last one week, shares of Pfizer Limited have slipped by -0.46%.

Pfizer Limited's Key Ratios

Pfizer Limited has a market cap of ₹174.90 billion, indicating a price to book ratio of 6.8762 and a price to sales ratio of 8.1666.

In the last 12-months Pfizer Limited’s revenue was ₹23.63 billion with a gross profit of ₹13.53 billion and an EBITDA of ₹7.00 billion. The EBITDA ratio measures Pfizer Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Pfizer Limited’s operating margin was 26.85% while its return on assets stood at 11.15% with a return of equity of 20.55%.

In Q2, Pfizer Limited’s quarterly earnings growth was a positive 187.5% while revenue growth was a negative 10.4%.

Pfizer Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

25.5244

PEG

Its diluted EPS in the last 12-months stands at ₹149.78 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Pfizer Limited’s profitability.

Pfizer Limited stock is trading at a EV to sales ratio of 7.6041 and a EV to EBITDA ratio of 20.42. Its price to sales ratio in the trailing 12-months stood at 8.1666.

Pfizer Limited stock pays annual dividends of ₹35 per share, indicating a yield of 2.6% and a payout ratio of 43.42%.

Balance sheet and cash flow metrics

Total Assets

₹40.01 billion

Total Liabilities

₹6.57 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

43.42%

Pfizer Limited ended 2024 with ₹40.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹40.01 billion while shareholder equity stood at ₹32.07 billion.

Pfizer Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹6.57 billion in other current liabilities, 457500000.00 in common stock, ₹31.62 billion in retained earnings and ₹5.27 billion in goodwill. Its cash balance stood at ₹366.00 million and cash and short-term investments were ₹18.82 billion. The company’s total short-term debt was ₹25,000,000 while long-term debt stood at ₹0.

Pfizer Limited’s total current assets stands at ₹25.25 billion while long-term investments were ₹0 and short-term investments were ₹229.50 million. Its net receivables were ₹1.52 billion compared to accounts payable of ₹2.17 billion and inventory worth ₹4.18 billion.

In 2024, Pfizer Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Pfizer Limited paid ₹0.43 in dividends in 2024.

Other key metrics

Current Trading Price

₹3837.5

52-Week High

₹4621.9458

52-Week Low

₹3377.4252

Analyst Target Price

₹

Pfizer Limited stock is currently trading at ₹3837.5 per share. It touched a 52-week high of ₹4621.9458 and a 52-week low of ₹4621.9458. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹3873.72 and 200-day moving average was ₹3927.64 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6686.5% of the company’s stock are held by insiders while 1658% are held by institutions.